Compare NIO Inc. (NIO) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NIO Inc. vs Revvity Inc — how do they compare? NIO Inc. trades at $3.67 (market cap $9.50B), while Revvity Inc trades at $124.14 (market cap $13.82B). The key difference: Revvity Inc is the larger of the two by market cap, and Revvity Inc pays a 0.23% dividend while NIO Inc. pays none. Which is the better fit depends on your goals.
| NIO | RVTY | |
|---|---|---|
Market Cap | $9.50B | $13.82B |
Sector | Consumer Cyclical | Technology |
52-Week High | $7.89 | $130.94 |
52-Week Low | $3.70 | $82.26 |
Enterprise Value | $7.40B | $16.14B |
Dividend Yield | — | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NIO trades at $3.79, down 0.26% today, with a bearish technical signal despite recent earnings beats. The company reported Q2 2026 revenue growth of 69.1% year-over-year to $4.74 billion (Seeking Alpha, 2026-09-03), but missed revenue expectations. Vehicle margins improved to 18.4%, and cash flow turned positive, yet net losses persist. Analyst consensus is mixed, with a $5.50 price target suggesting 45% upside from current levels.
Outlook: NIO shows operational progress with narrowing losses and brand diversification, but high debt and Chinese EV competition pose risks. The stock's low P/S ratio of 0.54 indicates potential undervaluation if profitability improves. Investors face volatility from macroeconomic headwinds and execution challenges in achieving sustained positive earnings.
RVTY trades at $127.08, down 2.41% over 24 hours, with a bullish technical signal driven by moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, supported by diagnostics growth and improved cash flow. Recent news includes the acquisition of Human Cell Design and product launches, indicating strategic expansion.
Outlook remains positive with a consensus price target of $136.20, offering ~7% upside, but high P/E of 59.54 poses valuation risk. Key opportunities include earnings momentum and innovation; risks involve premium valuation and competitive pressures in the healthcare sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
